Small Business Problems in the Drug Industry: Hearings Before the Subcommittee on Activities of Regulatory Agencies of the Select Committee on Small Business, House of Representatives, Ninetieth Congress, First[-second] Session[s] Pursuant to H. Res. 53 a Resolution Creating a Select Committee to Conduct Studies and Investigations of the Problems of Small Business, Volume 2U.S. Government Printing Office, 1967 Examines impact of pharmaceutical industry pricing policies on small firms, focusing on practices which allegedly violate antitrust laws. Part two continuation of hearings on the impact of pharmaceutical industry retail, wholesale, and manufacturing practices on small business. |
From inside the book
Results 1-5 of 15
Page 247
... Abrahamson , W. Vincent , president , Ortho Pharmaceutical Corp .... Anderson , E. B. , vice president and general counsel , Roche Labora- tories__ 717 556 Apple , William S. , executive director , American Pharmaceutical Association ...
... Abrahamson , W. Vincent , president , Ortho Pharmaceutical Corp .... Anderson , E. B. , vice president and general counsel , Roche Labora- tories__ 717 556 Apple , William S. , executive director , American Pharmaceutical Association ...
Page 717
... Abrahamson , presi- dent . Mr. Abrahamson , we are happy to welcome you for such testimony as you choose to give . Would you please give us your full name , address and also the names and addresses of those gentlemen who are present at ...
... Abrahamson , presi- dent . Mr. Abrahamson , we are happy to welcome you for such testimony as you choose to give . Would you please give us your full name , address and also the names and addresses of those gentlemen who are present at ...
Page 718
... ABRAHAMSON . We appreciate the opportunity to appear before the committee and provide a description of Ortho's distribution poli- cies and practices . My statement here will be confined only to Ortho Pharmaceutical Corp. Ortho has two ...
... ABRAHAMSON . We appreciate the opportunity to appear before the committee and provide a description of Ortho's distribution poli- cies and practices . My statement here will be confined only to Ortho Pharmaceutical Corp. Ortho has two ...
Page 720
... Abrahamson , in reading the statement of distribution policy which you filed with NWDA - I think your most recent filing was in August of 1966 - it is entirely consistent with your statement , and I am quoting from it only because it is ...
... Abrahamson , in reading the statement of distribution policy which you filed with NWDA - I think your most recent filing was in August of 1966 - it is entirely consistent with your statement , and I am quoting from it only because it is ...
Page 721
... Abrahamson , from our study of the wholesale sector of the industry , it would appear that businessmen engaged in ... ABRAHAMSON . As stated , our wholesalers make a 15 - percent dis- count plus a 4 - percent promotional allowance . Mr ...
... Abrahamson , from our study of the wholesale sector of the industry , it would appear that businessmen engaged in ... ABRAHAMSON . As stated , our wholesalers make a 15 - percent dis- count plus a 4 - percent promotional allowance . Mr ...
Common terms and phrases
ABRAHAMSON accounts acid agency Agreement APPLE AUBUCHON Baltimore basis bottle Chairman Chlorpheniramine Maleate clinics committee community pharmacist competition CORICIDIN correct corticosteroids corticotropin cost customers DEBOEST dexamethasone Diethylene glycol DINGELL direct dispensing distribution doctor dosage dose drugstore effect Federal food additive FORD give GODDARD going Government Health Center HORAN hospital industry INGOLIA Injection invoice labeling Laboratories Lederle LERNER Lilly list price manufacturers McKesson merchandise MOORE MORTON NWDA package patients percent Perphenazine Pfizer Pharmaceutical Association physicians POTVIN practice prednisone prescription drugs price list problem professional purchase quantity discounts question retail pharmacies Robinson-Patman Act Roche Roche Laboratories salers samples Schering SEARLE sell shipments SK&F Sodium specific statement subcommittee submit tablets TAISCH testimony therapy tion trade United Units daily vial WALKER wholesale distributors wholesalers
Popular passages
Page 566 - Oral suspension, containing in each teaspoonful (5 ml) the equivalent of 40 mg trimethoprim and 200 mg sulfamethoxazole, fruit-licorice flavored — bottles of 16 oz (1 pint) Roche Laboratories Division of Hoffmann-La Roche Inc. Nutley. New Jersey 071 10 Weight Dose — every 12 hours Ibs kgs Teaspoonfuls Tablets 20 9 1 teasp.
Page 453 - A complete batch formula for each batch size to be produced from the master-formula record, including a complete list of ingredients designated by names or codes sufficiently specific to indicate any special quality characteristic ; an accurate statement of the weight or measure of each ingredient...
Page 1073 - Checks, drafts, etc. All checks, drafts, or other orders for the payment of money, notes, or other evidences of indebtedness issued in the name of the corporation, shall be signed by such officer or officers, agent or agents of the...
Page 688 - Now, therefore, in consideration of the mutual promises and covenants described herein, the parties hereto, intending to be legally bound hereby, agree as follows.
Page 468 - Health or its duly authorized agent shall have free access at all reasonable hours to any factory, warehouse, or establishment in which foods, drugs, devices or cosmetics are manufactured, processed, packed or held for introduction into commerce, or to enter any vehicle being used to transport or hold such foods, drugs, devices, or cosmetics in commerce, for the purpose...
Page 1073 - DEPOSITS. All funds of the corporation shall be deposited from time to time to the credit of the corporation in such banks, trust companies or other depositories as the Board of Directors may select.
Page 450 - ... the methods used in, or the facilities or controls used for, its manufacture, processing, packing, or holding do not conform to or are not operated or administered in conformity with current good manufacturing practice...
Page 441 - If I can be of further assistance to you in this matter, please do not hesitate to call on me. Sincerely yours, CB JONES, Rear Admiral, US Navy, Chief of Legislative Affairs. Costs of nuclear propulsion in the "Enterprise...
Page 432 - Where a substance is both a new drug and a food additive, the submission of a new-drug application in accordance with the regulations appearing in Part 130 of this chapter will also be construed as a petition for the establishment of a regulation for the use of the substance as a food additive. A new-drug application will not be...
Page 432 - DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE FOOD AND DRUG ADMINISTRATION [21 CFR Part 121] Food Additives...